Elucidating the role of clofazimine for the treatment of tuberculosis.

Abstract

Clofazimine (CFZ), a riminophenazine and a key component of the treatment regimen for lepromatous leprosy, has been rehabilitated clinically for the treatment of multidrug-resistant tuberculosis (MDR-TB). Observational studies and a randomized control trial suggest efficacy in the treatment of MDR-TB and the potential for treatment shortening. Animal and… (More)
DOI: 10.5588/ijtld.16.0073

Topics

Cite this paper

@article{ODonnell2016ElucidatingTR, title={Elucidating the role of clofazimine for the treatment of tuberculosis.}, author={Max Roe O'Donnell and Nesri Padayatchi and John Metcalfe}, journal={The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease}, year={2016}, volume={20 12}, pages={52-57} }